logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11730711 B1

PDFFull Text
Date of Patent:
Aug. 22, 2023

Filed:

Feb. 12, 2021

Benefits of supplementation with n-acetylcysteine and glycine to improve glutathione levels

Applicants:

Société Des Produits Nestlé S.a., Vevey, CH;

Baylor College of Medicine, Houston, TX (US);

Inventors:

Stephen Kirnon, San Ramon, CA (US);

Eric Freedland, Marblehead, MA (US);

Rajagopal V. Sekhar, Missouri City, TX (US);

Assignees:

Baylor College of Medicine, Houston, TX (US);

Societe de Produits Nestle S.A., Vevey, CH;

Attorney:

K&L Gates LLP

Primary Examiner:

Jeffrey E Russel

Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 38/05 (2006.01); A61K 31/167 (2006.01); A61K 31/223 (2006.01); A61K 31/341 (2006.01); A61K 38/21 (2006.01); A61K 31/683 (2006.01); A61K 31/27 (2006.01); A61K 45/06 (2006.01); A61K 31/381 (2006.01); A61K 31/205 (2006.01); A23K 20/142 (2016.01); A23K 50/50 (2016.01); A61P 21/00 (2006.01); A61P 39/00 (2006.01); A61P 31/18 (2006.01); A61P 29/00 (2006.01); A61K 38/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A23K 20/142 (2016.05); A23K 50/50 (2016.05); A61K 31/167 (2013.01); A61K 31/205 (2013.01); A61K 31/223 (2013.01); A61K 31/27 (2013.01); A61K 31/341 (2013.01); A61K 31/381 (2013.01); A61K 31/683 (2013.01); A61K 38/02 (2013.01); A61K 38/05 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); A61P 21/00 (2018.01); A61P 29/00 (2018.01); A61P 31/18 (2018.01); A61P 39/00 (2018.01);
Abstract

Compositions and methods are related to utilizing glycine and N-acetylcysteine for a variety of medical conditions related to reduced levels of glycine, N-acetylcysteine, and/or glutathione, for example, muscle loss such as sarcopenia, HIV infection and other infections, organ damage such as those from diabetes and insulin resistance and diabetic nephropathy, cardiac function and failure such as preventing or improving heart failure, fatty liver, cancer prevention, and other conditions.

Find Patent Forward Citations

Loading…